Atlas Trials

A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users

Clinical trial NCT02192931 · COMPLETED

Trial details

NCT number
NCT02192931
Sponsor
Perry Renshaw
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DepressionDual DiagnosisDrug Addiction
Start date
2014-09-01
Primary completion
2023-01-31
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.